Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Saved in:
| Title: | Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. |
|---|---|
| Authors: | Richters L; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany., Gluz O; West German Study Group, Moenchengladbach, Germany.; Ev. Hospital Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany.; Women's Clinic and Breast Center, University Clinics Cologne, Cologne, Germany., Weber-Lassalle N; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany., Christgen M; Institute of Pathology, Medical School Hannover, Hannover, Germany., Haverkamp H; Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.; Now with Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany., Kuemmel S; West German Study Group, Moenchengladbach, Germany.; Interdisciplinary Breast Center, Kliniken Essen-Mitte, Evang. Hospital Essen-Mitte, Essen, Germany.; Department of Gynecology, Breast Center, Charité-Universitätsmedizin Berlin, Berlin, Germany., Kayali M; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany., Kates RE; West German Study Group, Moenchengladbach, Germany., Grischke EM; Women's Clinic, University Clinics Tübingen, Tübingen, Germany., Altmüller J; Cologne Center for Genomics, University of Cologne, Cologne, Germany.; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.; Core Unit Genomics, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany., Forstbauer H; Oncology Practice Network, Troisdorf, Germany., Thiele H; Cologne Center for Genomics, University of Cologne, Cologne, Germany., Braun M; Interdisciplinary Breast Center, Rotkreuz-Clinics Munich, Munich, Germany., Warm M; Breast Center, Municipal Hospital Holweide, Cologne, Germany., Ossowski A; Cologne Center for Genomics, University of Cologne, Cologne, Germany., Wuerstlein R; West German Study Group, Moenchengladbach, Germany.; Breast Center, Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital of Ludwig Maximilian University, Munich, Germany., Ernst C; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany., Graeser M; West German Study Group, Moenchengladbach, Germany.; Ev. Hospital Bethesda, Breast Center Niederrhein, Moenchengladbach, Germany.; Department of Gynecology, University Medical Center Hamburg, Hamburg, Germany., Linn SC; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Nitz U; West German Study Group, Moenchengladbach, Germany., Hauke J; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany., Kreipe HH; Institute of Pathology, Medical School Hannover, Hannover, Germany., Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany., Hahnen E; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.; Center for Integrated Oncology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany., Harbeck N; West German Study Group, Moenchengladbach, Germany.; Breast Center, Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital of Ludwig Maximilian University, Munich, Germany. |
| Source: | JAMA network open [JAMA Netw Open] 2025 Feb 03; Vol. 8 (2), pp. e2461639. Date of Electronic Publication: 2025 Feb 03. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2024.61639 |
